EPISODE · Feb 24, 2022 · 22 MIN
How Covid-19 mRNA research could cure HIV and cancer
from Kutad Gubilik's Listen Later · host The National News
Podcast: Beyond the Headlines (LS 31 · TOP 5% what is this?)Episode: How Covid-19 mRNA research could cure HIV and cancerPub date: 2021-05-06Get Podcast Transcript →powered by Listen411 - fast audio-to-text and summarizationWithin months of the emergence of coronavirus in late 2019 drug companies around the world were racing for a vaccine. Within a year, shots were being delivered into people’s arms. The speed at which the world developed not one but several different Covid-19 vaccines in seemingly record time has thrown into sharp relief other vaccine programmes that have toiled for years with no final breakthrough. HIV, the virus that causes Aids, kills nearly 700,000 every year, but has outwitted vaccine developers for more than three decades. Even regular influenzas can be deadly and our tools to stop it are very limited. But now, there is renewed hope that this could change – and that may be thanks to the work on Covid-19 vaccines. On this week's Beyond the Headlines, host James Haines-Young delves into how Covid-19 vaccines have already shaken up the drug industry and how what we are learning now could one day lead to tailor-made treatment for almost any ailment.The podcast and artwork embedded on this page are from The National News, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
What this episode covers
Podcast: Beyond the Headlines Episode: How Covid-19 mRNA research could cure HIV and cancer Pub date: 2021-05-06 Details: https://www.listennotes.com/e/4803898da669462aa11185156693e7b8/ The podcast and artwork embedded on this page are from The National News, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
NOW PLAYING
How Covid-19 mRNA research could cure HIV and cancer
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m